(Q27496667)

(Redirected from Q21261869)

English

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

scientific article

In more languages

Statements

scholarly article

0 references

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease (English)

0 references

0 references

0 references

0 references

fatty liver disease

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Françoise Imbert-Bismut

5

object named as

Françoise Imbert-Bismut

0 references

Brigitte Le Bail

11

object named as

Brigitte Le Bail

0 references

Thierry Poynard

object named as

Thierry Poynard

13

0 references

object named as

Mona Munteanu

8

0 references

Dominique Thabut

9

object named as

Dominique Thabut

0 references

1

object named as

Vlad Ratziu

0 references

Djamila Messous

4

object named as

Djamila Messous

0 references

Frédéric Charlotte

3

object named as

Frederic Charlotte

0 references

2

object named as

Julien Massard

0 references

Luninita Bonyhay

6

object named as

Luninita Bonyhay

0 references

7

object named as

Mohamed Tahiri

0 references

Jean François Cadranel

10

object named as

Jean François Cadranel

0 references

Victor de Lédinghen

12

object named as

Victor de Ledinghen

0 references

author name string

Françoise Imbert-Bismut

5

0 references

language of work or name

0 references

publication date

14 February 2006

0 references

2006

0 references

BMC Gastroenterology

1 reference

6

0 references

6

0 references

1

0 references

https://scigraph.springernature.com/pub.10.1186/1471-230x-6-6

0 references

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

20 March 2017

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

20 March 2017

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

20 March 2017

Liver fibrosis in overweight patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

20 March 2017

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

7 April 2017

Nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

7 April 2017

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

7 April 2017

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Nonalcoholic fatty liver disease: a review of current understanding and future impact

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

The epidemiology of fatty liver

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

AGA technical review on nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

alpha 2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Appropriateness of liver biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Is liver biopsy useful in the evaluation of patients with chronically elevated liver enzymes?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

29 September 2017

Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

2 June 2018

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

2 June 2018

The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

2 June 2018

A 21-year experience with major hemorrhage after percutaneous liver biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

2 June 2018

Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

2 June 2018

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Prediction of liver fibrosis in patients with features of the metabolic syndrome regardless of alcohol consumption

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Silent non-alcoholic fatty liver disease-a clinical-histological study

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

FibroTest-FibroSURE™: towards a universal biomarker of liver fibrosis?

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-6-6

21 January 2018

Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386692

27 November 2018

Alpha2-Macroglobulin and Proliferative Retinopathy in Type 1 Diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/16503961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations

1 reference

https://pubmed.ncbi.nlm.nih.gov/16503961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of alpha-2-macroglobulin of human serum in the fixation in vitro of iodine-131 labeled bovine insulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16503961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of insulin incorporation into .alpha.2-macroglobulin: implications for the study of peptide and growth factor binding

1 reference

https://pubmed.ncbi.nlm.nih.gov/16503961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers as a first-line estimate of injury in chronic liver diseases: time for a moratorium on liver biopsy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16503961

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-230X-6-6

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27496667&oldid=2080108173"